Ann: ResApp Signs MOU to Develop Respiratory App for Consumers, page-214

I have trouble justifying this deal with RB as an indicator tool when we are trying to negotiate deals with telehealth providers for a diagnostic tool by using the exact same AI. And call me cynical but this sounds like the exact same deal with Sanofi which ended in tears.

From the link above: "The aim is to develop a smartphone app for consumers using ResApp’s cough-based algorithms to identify different respiratory conditions and provide recommended next steps."